Literature DB >> 10444359

Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis.

P V Voulgari1, G Kolios, G K Papadopoulos, A Katsaraki, K Seferiadis, A A Drosos.   

Abstract

The aim of our study was to evaluate the role of proinflammatory cytokines: tumor necrosis factor alpha (TNFalpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6), as well as the possible contribution of interleukin-10 (IL-10) in anemia of chronic disease (ACD) of rheumatoid arthritis (RA) patients. We measured the serum levels of TNFalpha, IL-1beta, and IL-6 in 105 anemic and 127 nonanemic RA patients. We also investigated the effects of the above cytokines on the development of burst-forming units-erythroid (BFUe) and colony-forming units-erythroid (CFUe) in bone marrow cultures. Anemic patients had significantly higher serum levels of TNFalpha, IL-1beta, and IL-6 compared to nonanemics. Serum IL-10 levels were low and there was no significant difference in IL-10 concentrations between anemic and nonanemic patients. Proinflammatory cytokines inhibited proliferation of BFUe and CFUe. IL-10 did not decrease the erythroid colony growth. Proinflammatory cytokines may play a role in the pathogenesis of ACD in RA patients. Low levels of IL-10 possibly contribute to the development of ACD. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444359     DOI: 10.1006/clim.1999.4736

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  27 in total

Review 1.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

2.  Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation.

Authors:  Gaith Semrin; Douglas S Fishman; Athos Bousvaros; Anna Zholudev; Andrew C Saunders; Catherine E Correia; Elizabeta Nemeth; Richard J Grand; David A Weinstein
Journal:  Inflamm Bowel Dis       Date:  2006-12       Impact factor: 5.325

3.  Resveratrol reduces store-operated Ca2+ entry and enhances the apoptosis of fibroblast-like synoviocytes in adjuvant arthritis rats model via targeting ORAI1-STIM1 complex.

Authors:  Jinsen Lu; Jiazhao Yang; Yongshun Zheng; Shiyuan Fang; Xiaoyu Chen
Journal:  Biol Res       Date:  2019-08-19       Impact factor: 5.612

4.  Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function.

Authors:  L Grigorian Shamagian; A Varela Roman; J M Garcia-Acuña; P Mazon Ramos; A Virgos Lamela; J R Gonzalez-Juanatey
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

Review 5.  Anaemia in inflammatory rheumatic diseases.

Authors:  Günter Weiss; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

Review 6.  The erythroblastic island as an emerging paradigm in the anemia of inflammation.

Authors:  Jimmy Hom; Brian M Dulmovits; Narla Mohandas; Lionel Blanc
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

7.  Inhibiting interleukin-6 in rheumatoid arthritis.

Authors:  Ernest Choy
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

8.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

9.  Clinical observation on the treatment of male neoplastic anemia with Yixuesheng capsule combined with recombination human erythropoietin.

Authors:  Zhi Cheng; Jia-Li Wu; Jun-Fa Chen
Journal:  Chin J Integr Med       Date:  2009-03-07       Impact factor: 1.978

Review 10.  TNFalpha blockade in human diseases: mechanisms and future directions.

Authors:  Maida Wong; David Ziring; Yael Korin; Sheetal Desai; Sungjin Kim; Jan Lin; David Gjertson; Jonathan Braun; Elaine Reed; Ram Raj Singh
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.